Surgical site infections (SSIs) are a significant healthcare system burden
SSIs prolong healing and hospital length of stay, increase costs and reduce patients’ quality of life.30
Each SSI may have the following impact
9.7 days
Average extended hospital length of stay.30,31
>$20,000 USD
Increase in the cost of hospitalization.30,31
2-11 fold
Increased risk of mortality.30
Myriad has a low rate of device-related complications across a range of complex, acute and chronic wounds
- Myriad-treated wounds with a high risk of infection demonstrated 0% SSI rates in most cases.1-7,11,26
- Low infection and graft loss rates, even in contaminated defects.1-7,11,26
- Facilitates rapid vascularization and tissue fill, typically with a single application.1-7,11,26
Myriad published SSI and median application rates
Reference | CDC Contamination score | Sample size | SSI rate | Median product applications |
---|---|---|---|---|
Lawlor et al. (1) Lower extremity reconstruction | Grade II (8/230 cases) Grade III (112/230 cases) | 130 | 0% | 1.0 |
Cormican et al.(2)Traumatic and acute defects | Grade II (8/13 cases) Grade III (5/13 cases) | 13 | 0% | 1.0 |
Taarea et al.(4) Emergency open abdomen | Grade II | 3 | 0% | 1.0 |
Bosque et al.(3)Lower extremity reconstruction | Grade IV | 50 | 0% | 1.0 |
Chaffin et al.(5)Pilonidal sinus | Grade III | 6 | 0% | 1.0 |
Chaffin et al.(6)Hidradenitis suppurativa | Grade III | 8 | 0% | 1.0 |
Desvigne et al.(11)Non-healing wounds | Grade II (5/9 cases) Grade III (4/9 cases) | 9 | 11% | 1.0 |
Hsu et al. (26) Anal fistula | Grade III | 14 | 0% | 1.0 |
Bohn et al.(7) Exposed structures | Grade II (4/6 cases) Grade III (2/6 cases) | 6 | 0% | 1.0 |
Myriad may help reduce the overall cost of care
Enables earlier intervention
Despite the presence of contamination.1-4
Reduces the frequency of NPWT dressing changes
By working synergistically with NPWT.2,3
Minimal complications
Low infection rate and graft loss, even in contaminated defects1-7,11,26
A versatile portfolio for soft tissue repair

Myriad Matrix™
Multiple layers of AROA ECM to enable regeneration of organized, functional tissue.

Myriad Morcells™
A conformable graft of morselized Myriad. Ideal for irregular, tunneled or undermined wounds.

Myriad Morcells Fine™
A finer particulate of Myriad Morcells. Ideal for irregular, tunneled or undermined wounds.
AROA ECM™
Our foundation technology
Derived from ovine forestomach, the AROA ECM technology is a patented platform for our soft tissue repair and reconstruction portfolio. It regenerates functional tissue, enabling clinicians to achieve more for patients.